|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Weinberg BA, Marshall JL and Salem ME: The
growing challenge of young adults with colorectal cancer. Oncology
(Williston Park). 31:381–389. 2017.PubMed/NCBI
|
|
3
|
Sun Y, Zheng ZP, Li H, Zhang HQ and Ma FQ:
ANRIL is associated with the survival rate of patients with
colorectal cancer, and affects cell migration and invasion in
vitro. Mol Med Rep. 14:1714–1720. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhao J, Xu J, Shang AQ and Zhang R: A
Six-LncRNA expression signature associated with prognosis of
colorectal cancer patients. Cell Physiol Biochem. 50:1882–1890.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Joranger P, Nesbakken A, Sorbye H, Hoff G,
Oshaug A and Aas E: Survival and costs of colorectal cancer
treatment and effects of changing treatment strategies: A model
approach. Eur J Health Econ. 21:321–334. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Beermann J, Piccoli MT, Viereck J and Thum
T: Non-coding RNAs in development and disease: Background,
mechanisms, and therapeutic approaches. Physiol Rev. 96:1297–1325.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guarnerio J, Zhang Y, Cheloni G, Panella
R, Mae Katon J, Simpson M, Matsumoto A, Papa A, Loretelli C, Petri
A, et al: Intragenic antagonistic roles of protein and circRNA in
tumorigenesis. Cell Res. 29:628–640. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vo JN, Cieslik M, Zhang Y, Shukla S, Xiao
L, Zhang Y, Wu YM, Dhanasekaran SM, Engelke CG, Cao X, et al: The
landscape of circular RNA in cancer. Cell. 176:869–881.e13. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zheng X, Chen L, Zhou Y, Wang Q, Zheng Z,
Xu B, Wu C, Zhou Q, Hu W, Wu C and Jiang J: A novel protein encoded
by a circular RNA circPPP1R12A promotes tumor pathogenesis and
metastasis of colon cancer via Hippo-YAP signaling. Mol Cancer.
18:472019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang X, Li Z, Zhang Q, Wang W, Li B, Wang
L, Xu Z, Zeng A, Zhang X, Zhang X, et al: Circular RNA AKT3
upregulates PIK3R1 to enhance cisplatin resistance in gastric
cancer via miR-198 suppression. Mol Cancer. 18:712019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang G, Zhang T, Ye J, Yang J, Chen C, Cai
S and Ma J: Circ-ITGA7 sponges miR-3187-3p to upregulate ASXL1,
suppressing colorectal cancer proliferation. Cancer Manag Res.
11:6499–6509. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mao W, Huang X, Wang L, Zhang Z, Liu M, Li
Y, Luo M, Yao X, Fan J and Geng J: Circular RNA hsa_circ_0068871
regulates FGFR3 expression and activates STAT3 by targeting
miR-181a-5p to promote bladder cancer progression. J Exp Clin
Cancer Res. 38:1692019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang H, Zhu M, Shan X, Zhou X, Wang T,
Zhang J, Tao J, Cheng W, Chen G, Li J, et al: A panel of
seven-miRNA signature in plasma as potential biomarker for
colorectal cancer diagnosis. Gene. 687:246–254. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wong CC, Wong CM, Tung EK, Man K and Ng
IO: Rho-kinase 2 is frequently overexpressed in hepatocellular
carcinoma and involved in tumor invasion. Hepatology. 49:1583–1594.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Flynn R, Paz K, Du J, Reichenbach DK,
Taylor PA, Panoskaltsis-Mortari A, Vulic A, Luznik L, MacDonald KK,
Hill GR, et al: Targeted Rho-associated kinase 2 inhibition
suppresses murine and human chronic GVHD through a Stat3-dependent
mechanism. Blood. 127:2144–2154. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yin Y, Long J, He Q, Li Y, Liao Y, He P
and Zhu W: Emerging roles of circRNA in formation and progression
of cancer. J Cancer. 10:5015–5021. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee SY, Choi JE, Jeon HS, Hong MJ, Choi
YY, Kang HG, Yoo SS, Lee EB, Jeong JY, Lee WK, et al: A genetic
variation in microRNA target site of KRT81 gene is associated with
survival in early-stage non-small-cell lung cancer. Ann Oncol.
26:1142–1148. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jeck WR, Sorrentino JA, Wang K, Slevin MK,
Burd CE, Liu J, Marzluff WF and Sharpless NE: Circular RNAs are
abundant, conserved, and associated with ALU repeats. RNA.
19:141–157. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang Y, Liu H, Li W, Yu J, Li J, Shen Z,
Ye G, Qi X and Li G: CircRNA_100269 is downregulated in gastric
cancer and suppresses tumor cell growth by targeting miR-630. Aging
(Albany NY). 9:1585–1594. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang L, Zhou Q, Qiu Q, Hou L, Wu M, Li J,
Li X, Lu B, Cheng X, Liu P, et al: CircPLEKHM3 acts as a tumor
suppressor through regulation of the miR-9/BRCA1/DNAJB6/KLF4/AKT1
axis in ovarian cancer. Mol Cancer. 18:1442019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen L, Nan A, Zhang N, Jia Y, Li X, Ling
Y, Dai J, Zhang S, Yang Q, Yi Y and Jiang Y: Circular RNA 100146
functions as an oncogene through direct binding to miR-361-3p and
miR-615-5p in non-small cell lung cancer. Mol Cancer. 18:132019.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang X, Zhang Y, Huang L, Zhang J, Pan F,
Li B, Yan Y, Jia B, Liu H, Li S and Zheng W: Decreased expression
of hsa_circ_001988 in colorectal cancer and its clinical
significances. Int J Clin Exp Pathol. 8:16020–16025.
2015.PubMed/NCBI
|
|
24
|
Zhuo F, Lin H, Chen Z, Huang Z and Hu J:
The expression profile and clinical significance of circRNA0003906
in colorectal cancer. Onco Targets Ther. 10:5187–5193. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li X, Wang J, Zhang C, Lin C, Zhang J,
Zhang W, Zhang W, Lu Y, Zheng L and Li X: Circular RNA circITGA7
inhibits colorectal cancer growth and metastasis by modulating the
Ras pathway and upregulating transcription of its host gene ITGA7.
J Pathol. 246:166–179. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen RX, Chen X, Xia LP, Zhang JX, Pan ZZ,
Ma XD, Han K, Chen JW, Judde JG, Deas O, et al:
N6-methyladenosine modification of circNSUN2 facilitates
cytoplasmic export and stabilizes HMGA2 to promote colorectal liver
metastasis. Nat Commun. 10:46952019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu W, Ma W, Yuan Y, Zhang Y and Sun S:
Circular RNA hsa_circRNA_103809 promotes lung cancer progression
via facilitating ZNF121-dependent MYC expression by sequestering
miR-4302. Biochem Biophys Res Commun. 500:846–851. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xie F, Li Y, Wang M, Huang C, Tao D, Zheng
F, Zhang H, Zeng F, Xiao X and Jiang G: Circular RNA BCRC-3
suppresses bladder cancer proliferation through miR-182-5p/p27
axis. Mol Cancer. 17:1442018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Su H, Tao T, Yang Z, Kang X, Zhang X, Kang
D, Wu S and Li C: Circular RNA cTFRC acts as the sponge of
MicroRNA-107 to promote bladder carcinoma progression. Mol Cancer.
18:272019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu Z, Sun F, Hong Y, Liu Y, Fen M, Yin K,
Ge X, Wang F, Chen X and Guan W: MEG2 is regulated by miR-181a-5p
and functions as a tumour suppressor gene to suppress the
proliferation and migration of gastric cancer cells. Mol Cancer.
16:1332017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Petrillo M, Zannoni GF, Beltrame L,
Martinelli E, DiFeo A, Paracchini L, Craparotta I, Mannarino L,
Vizzielli G, Scambia G, et al: Identification of high-grade serous
ovarian cancer miRNA species associated with survival and drug
response in patients receiving neoadjuvant chemotherapy: A
retrospective longitudinal analysis using matched tumor biopsies.
Ann Oncol. 27:625–634. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Han P, Li JW, Zhang BM, Lv JC, Li YM, Gu
XY, Yu ZW, Jia YH, Bai XF, Li L, et al: The lncRNA CRNDE promotes
colorectal cancer cell proliferation and chemoresistance via
miR-181a-5p-mediated regulation of Wnt/β-catenin signaling. Mol
Cancer. 16:92017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lv SY, Shan TD, Pan XT, Tian ZB, Liu XS,
Liu FG, Sun XG, Xue HG, Li XH, Han Y, et al: The lncRNA ZEB1-AS1
sponges miR-181a-5p to promote colorectal cancer cell proliferation
by regulating Wnt/β-catenin signaling. Cell Cycle. 17:1245–1254.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhu L, Zhang Q, Li S, Jiang S, Cui J and
Dang G: Interference of the long noncoding RNA CDKN2B-AS1
upregulates miR-181a-5p/TGFβI axis to restrain the metastasis and
promote apoptosis and senescence of cervical cancer cells. Cancer
Med. 8:1721–1730. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shang A, Wang W, Gu C, Chen W, Lu W, Sun Z
and Li D: Long non-coding RNA CCAT1 promotes colorectal cancer
progression by regulating miR-181a-5p expression. Aging (Albany
NY). 12:8301–8320. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yang M, Zhai X, Ge T, Yang C and Lou G:
miR-181a-5p promotes proliferation and invasion and inhibits
apoptosis of cervical cancer cells via regulating inositol
polyphosphate-5-phosphatase A (INPP5A). Oncol Res. 26:703–712.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li M, Ke J, Wang Q, Qian H, Yang L, Zhang
X, Xiao J, Ding H, Shan X, Liu Q, et al: Upregulation of ROCK2 in
gastric cancer cell promotes tumor cell proliferation, metastasis
and invasion. Clin Exp Med. 17:519–529. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hu J, Wang L, Zhao W, Huang Y, Wang Z and
Shen H: mi-R4435-2HG promotes proliferation and inhibits apoptosis
of cancer cells in ovarian carcinoma by upregulating ROCK2. Oncol
Lett. 19:1305–1309. 2020.PubMed/NCBI
|
|
39
|
Pranatharthi A, Thomas P, Udayashankar AH,
Bhavani C, Suresh SB, Krishna S, Thatte J, Srikantia N, Ross CR and
Srivastava S: RhoC regulates radioresistance via crosstalk of ROCK2
with the DNA repair machinery in cervical cancer. J Exp Clin Cancer
Res. 38:3922019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Qiu Y, Yuan R, Zhang S, Chen L, Huang D,
Hao H and Shao J: Rock2 stabilizes β-catenin to promote tumor
invasion and metastasis in colorectal cancer. Biochem Biophys Res
Commun. 467:629–637. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang X, Sun D, Tai J, Chen S, Yu M, Ren D
and Wang L: TFAP2C promotes stemness and chemotherapeutic
resistance in colorectal cancer via inactivating hippo signaling
pathway. J Exp Clin Cancer Res. 37:272018. View Article : Google Scholar : PubMed/NCBI
|
